Parkinson’s disease (PD) is a neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Oxidative stress is increasingly being discussed as a key process in the development and progression of the disease. This is triggered and maintained by multiple factors, including mitochondrial dysfunction, defective dopamine metabolism and chronic neuroinflammation. The resulting imbalance between reactive oxygen species (ROS) and antioxidant defense systems leads to pronounced cellular damage, which ultimately drives the degeneration of dopaminergic cells. Despite intensive research, no curative therapy exists to date.
You May Also Like
- Geriatric patients
Micronutrient Intake in Older Adults
- Crohn's disease: focus on long-term results
“Top-down” approach or classic step therapy?
- SwissDiab Study: New Analysis Published
How are diabetes complications associated with quality of life?
- Pre-acclimatization on Mount Everest
Exploring the physiological limits
- Viloxazine for ADHD
A non-stimulating option—but with limited evidence
- Preclinical study on phytotherapeutic agent
Active ingredient combination of peppermint and caraway oil modified fecal microbiota
- Casuistry
Rituximab used effectively against IgG4-RD colitis
- Sarcoidosis